1. GALNT2 targeted by miR-139-5p promotes proliferation of clear cell renal cell carcinoma via inhibition of LATS2 activation
   Haisheng Yi et al, 2024, Discover Oncology CrossRef
2. Downregulation of circ_0119412 expression inhibits malignant progression of breast cancer by targeting the miR-1205/GALNT6 pathway in vivo and in vitro
   Jianhua Liu et al, 2023, Archives of Medical Science CrossRef
3. Polypeptide N-Acetylgalactosaminyltransferase 14 (GALNT14) as a Chemosensitivity-Related Biomarker for Osteosarcoma
   Qiong Xi et al, 2023, Journal of Oncology CrossRef
4. Increased expression of the pathological O-glycosylated form of oncofetal fibronectin in the multidrug resistance phenotype of cancer cells
   Jhenifer Santos dos Reis et al, 2023, Matrix Biology CrossRef
5. A seven‐DNA methylation signature as a novel prognostic biomarker in breast cancer
   Chuntao Tao et al, 2020, Journal of Cellular Biochemistry CrossRef
6. Selectins: An Important Family of Glycan-Binding Cell Adhesion Molecules in Ovarian Cancer
   Ayon A. Hassan et al, 2020, Cancers CrossRef
7. Elevated GALNT10 expression identifies immunosuppressive microenvironment and dismal prognosis of patients with high grade serous ovarian cancer
   Guodong Zhang et al, 2020, Cancer Immunology, Immunotherapy CrossRef
8. Meta‐analysis of microarray data to determine gene indicators involved in the cisplatin resistance in ovarian cancer
   Somayeh Hashemi Sheikhshabani et al, 2023, Cancer Reports CrossRef
9. The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression
   Razan Sheta et al, 2019, International Journal of Molecular Sciences CrossRef
10. Mucin-Type O-GalNAc Glycosylation in Health and Disease
    Ieva Bagdonaite et al, 2021, The Role of Glycosylation in Health and Disease CrossRef
11. Pan-Cancer Analysis of GALNT6 with Potential Implications for Prognosis and Tumor Microenvironment in Human Cancer Based on Bioinformatics and qPCR Verification
    Yue Shao et al, 2024, International Journal of General Medicine CrossRef
12. Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the O-glycoproteome by the Macrophage Galactose-Like C-Type Lectin (MGL)
    Chiara Napoletano et al, 2020, Cancers CrossRef
13. Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy
    Razan Sheta et al, 2020, Journal of Translational Medicine CrossRef
14. Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in Colorectal Cancer
    Makiko Ogawa et al, 2022, Frontiers in Oncology CrossRef
15. GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers
    Wey-Ran Lin et al, 2020, International Journal of Molecular Sciences CrossRef
16. The GALNT6‑LGALS3BP axis promotes breast cancer cell growth
    Ryuichiro Kimura et al, 2019, International Journal of Oncology CrossRef
17. LncRNA PSMA3‐AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR‐378a‐3p/GALNT3 axis
    Zhihong Xu et al, 2021, Environmental Toxicology CrossRef
18. Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer
    Yibin Liu et al, 2023, Mediators of Inflammation CrossRef
19. GalNAc-T3 and MUC1, a combined predictor of prognosis and recurrence in solitary pulmonary adenocarcinoma initially diagnosed as malignant solitary pulmonary nodule (≤ 3 cm)
    Qiang Xie et al, 2020, Human Cell CrossRef
20. Glycosyltransferase-related prognostic and diagnostic biomarkers of uterine corpus endometrial carcinoma
    Jiaoqi Wu et al, 2023, Computers in Biology and Medicine CrossRef
21. EFEMP2 Mediates GALNT14-Dependent Breast Cancer Cell Invasion
    Tao Zuo et al, 2018, Translational Oncology CrossRef
22. Genome‐wide methylomic analyses identify prognostic epigenetic signature in lower grade glioma
    Wenna Guo et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
23. Protein Glycosylation as Biomarkers in Gynecologic Cancers
    Hung Shen et al, 2022, Diagnostics CrossRef